PCa is an androgen-dependent malignancy in which androgen and the androgen receptor (AR) play a crucial role (7, 8), with the androgen/AR axis and the gonadotropin-releasing hormone (GnRH)/GnRH receptor pathway playing pivotal roles in the initiation and progression of PCa. The gene discussed is GNRH1; the disease is posterior cortical atrophy.